Does MEDROXYPROGESTERONE Cause Red cell distribution width increased? 16 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 16 reports of Red cell distribution width increased have been filed in association with MEDROXYPROGESTERONE (Provera). This represents 0.2% of all adverse event reports for MEDROXYPROGESTERONE.
16
Reports of Red cell distribution width increased with MEDROXYPROGESTERONE
0.2%
of all MEDROXYPROGESTERONE reports
0
Deaths
8
Hospitalizations
How Dangerous Is Red cell distribution width increased From MEDROXYPROGESTERONE?
Of the 16 reports, 8 (50.0%) required hospitalization, and 9 (56.3%) were considered life-threatening.
Is Red cell distribution width increased Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for MEDROXYPROGESTERONE. However, 16 reports have been filed with the FAERS database.
What Other Side Effects Does MEDROXYPROGESTERONE Cause?
Meningioma (1,364)
Drug dose omission by device (510)
Device leakage (500)
Incorrect dose administered by device (410)
Drug ineffective (403)
Off label use (390)
Syringe issue (354)
Needle issue (346)
Headache (288)
Device occlusion (284)
What Other Drugs Cause Red cell distribution width increased?
CLOZAPINE (439)
METHOTREXATE (210)
ALEMTUZUMAB (202)
RITUXIMAB (198)
PREDNISONE (178)
PALBOCICLIB (171)
ADALIMUMAB (144)
METHYLPREDNISOLONE (123)
ECULIZUMAB (110)
TOCILIZUMAB (108)
Which MEDROXYPROGESTERONE Alternatives Have Lower Red cell distribution width increased Risk?
MEDROXYPROGESTERONE vs MEDROXYPROGESTERONE\MEDROXYPROGESTERONE
MEDROXYPROGESTERONE vs MEFENAMIC ACID
MEDROXYPROGESTERONE vs MEFLOQUINE
MEDROXYPROGESTERONE vs MEGESTROL
MEDROXYPROGESTERONE vs MEGLUMINE